contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


demant-as-investor-news-demant-afslutter-frasalg-af-oticon-medical

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Demant er aktiv inden for medicinsk teknologi. Virksomheden har specialiseret sig i udvikling af høreapparater. I dag opererer virksomheden på globalt plan, hvor produkterne sælges under forskellige mærker som Bernafon og Sonice. Produkterne tilgås via virksomhedens distributører og salgskanaler. Ud over hovedaktiviteterne forsker virksomheden inden for diagnostik til måling af hørelseskvalitet. Virksomheden blev grundlagt i 1904 og har hovedkontor med beliggenhed i Smørum.

Demant

31.3.2026 11:41:44 CEST | Demant A/S | Investor NyhederInvestor news31. marts 2026Demant afslutter frasalg af Oticon MedicalI forlængelse af selskabsmeddelelse nr. 2025-11, der blev offentliggjort...

<p class="prs-announcement__byline">31.3.2026 11:41:44 CEST | Demant A/S |    Investor Nyheder</p><table class="prs-table"><tbody><tr><td><p><strong>Investor news</strong></p></td><td><p><strong>31</strong><strong>. marts 2026</strong></p></td></tr></tbody></table><p><strong>Demant afslutter frasalg af Oticon Medical</strong></p><p></p><p></p><p>I forlængelse af selskabsmeddelelse nr. 2025-11, der blev offentliggjort den 22. oktober 2025, har Demant i dag afsluttet frasalget af Oticon Medical til Impilo.</p><p>&nbsp;</p><p></p><table class="prs-table"><tbody><tr><td><p><em>Yderligere information:</em></p><p>Søren Nielsen, koncernchef og adm. direktør</p><p>Telefon +45 3917 7300</p><p><a href="http://www.demant.com">www.demant.com</a></p></td><td><p><em>Øvrige kontaktpersoner:</em></p><p>René Schneider, CFO</p><p>Peter Pudselykke, Head of Investor Relations</p><p>Gustav Høegh, Investor Relations Officer</p><p>Maribel Alonso Francisco, Communication Manager</p></td></tr></tbody></table><h4>Kontakter</h4><ul>    <li>        Maribel Alonso Francisco, Communication Manager, +45 3171 9261, <a href="mailto:msbl@demant.com">msbl@demant.com</a>    </li></ul><h4>Vedhæftninger</h4><ul>    <li>        <a href="https://via.ritzau.dk/ir-files/13560112/14859215/17548/Investor%20news%20-%20Demant%20afslutter%20frasalg%20af%20Oticon%20Medical.pdf">Investor news - Demant afslutter frasalg af Oticon Medical.pdf</a>    </li></ul>

Demant A/S: Investor news - Demant afslutter frasalg af Oticon Medical

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation

Nordea Bank

Aktionær i Nordea? Det er nemmere end nogensinde at deltage i Nordeas generalforsamling takket være nyt digitalt setup